Search

Your search keyword '"Buffi N"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Buffi N" Remove constraint Author: "Buffi N" Publisher elsevier bv Remove constraint Publisher: elsevier bv
159 results on '"Buffi N"'

Search Results

1. Testing free PSA percentage as a tool in predicting future risk of developing prostate cancer: A system wide analysis of a contemporary North American cohort

2. Radical cystectomy versus trimodal therapy for non-metastatic muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohort

3. The impact of radical prostatectomy versus radiation therapy on cancer-specific mortality for patients with localized prostate cancer and positive nodal disease: An analysis of other cause mortality weighted cohort

4. Comparing PSA screening patterns and their role as predictor of prostate cancer incidence and mortality: A system wide analysis of a contemporary North American cohort

5. Active surveillance for prostate cancer in real-world setting: Exploring racial disparities in surveillance intensity and cancer control outcomes

6. Development and validation of a novel nomogram to predict lymph node invasion in upper tract urothelial carcinoma

7. Differential impact of prostate-specific antigen screening pattern on prostate cancer-mortality among non-Hispanic black and non-Hispanic white men: A large, urban health system cohort analysis

8. NODESAFE nomogram: A novel score system to predict lymph node involvement at the time of nephrectomy or nodal recurrence in non-metastatic renal cell carcinoma

9. The role of cytoreductive nephrectomy in metastatic clear cell carcinoma: Analisys of an other-cause mortality matched population from the contemporary immunotherapy era

10. Active surveillance follow-up for prostate cancer: From guidelines to real-world clinical practice

11. The impact of radical prostatectomy versus radiation therapy on cancer-specific-mortality for non-metastatic prostate cancer: Analysis of an other-cause-mortality matched cohort

12. Association of area of deprivation index with prostate cancer incidence and lethality over a contemporary North American cohort

13. What happens to patients with a PI-RADS 5 lesion and a negative prostate biopsy? Long term follow up of a single institutional experience

14. Decoding benign renal cortical lesions: A machine learning approach from the INMARC registry

15. Impact of lymphovascular invasion on survival of surgically treated patients with upper tract urothelial carcinoma: A nationwide analysis

16. Midlife baseline PSA as a predictor of lethal prostate cancer: Racial differences between black and white men

17. Impact of positive surgical margin after radical and partial nephrectomy for renal cell carcinoma: A multicenter analysis

18. Comparative analysis of oncological and functional outcomes of radical and partial nephrectomy in pT3aN0M0 renal cell carcinoma: A multicenter propensity score-matched analysis

19. Superiority of midlife baseline prostate-specific antigen value over PSA doubling time and velocity in the prediction of lethal prostate cancer development, and mortality: A system wide analysis of a racially diverse North American cohort

20. Multi-institutional European outcomes of supervised unexperienced resident in transurethral resection of bladder cancer: The importance of a standardized program, the ENTRY project working group

21. Multi-imaging model for local staging and targeted treatment of localized prostate cancer using high-intensity focused ultrasound (HIFU) focal therapy

22. A dedicated screening for early detection of prostate cancer in men with germline mutations in DNA-repair genes

23. The role of Mayo Adhesive Probability score in operative outcomes: A single center prospective analysis

26. Development of BIFECTA: A surgical success score for percutaneous microwave ablation of renal masses and validation of PADUA, SPARE and R.E.N.A.L. nephrometry scores

27. Adherent perinephric fat as predictor of post-operative functional recovery after robot-assisted partial nephrectomy

28. Renal cell carcinoma with venous thrombus: A retrospective single center surgical and oncological analysis

30. Developing of a novel nephrometry score to predict the outcomes of percutaneous ablation of renal masses

33. Techniques and outcomes of robot-assisted partial nephrectomy for the treatment of multiple ipsilateral renal masses

34. Accuracy of a new electronic nose (ENOSE) for prostate cancer diagnosis in urine samples

36. The relationship between adherent perinephric fat and the Mayo Adhesive Probability (MAP) score and post-operative functional outcomes in patients subjected to robot-assisted partial nephrectomy

37. Multiple ipsilateral renal masses treated with robot-assisted partial nephrectomy: A multi-institutional series

39. Developing of a novel nephrometry score to predict the outcomes of percutaneous ablation of renal masses: The PCT score

40. Post-biopsy cell-free DNA from blood in primary prostate cancer: How to get genetics data for decision making

41. [18F]-FDG PET/CT for bladder cancer staging and decision-making in patients with High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC)

42. Are nephrometry scores accurate for the prediction of outcomes in patients with renal angiomyolipoma treated with robot-assisted partial nephrectomy? A multi-institutional analysis

43. Head-to-head comparison between high-resolution microultrasound imaging and multiparametric MRI in detecting and local staging of bladder cancer: the BUS-MISS protocol

45. Additional value of 68GA-PSMA PET in patients who underwent choline-pet for biochemical recurrence after radical treatment for prostate cancer

46. Xpert bladder monitor may avoid cystoscopies in patients under “active surveillance” for recurrent bladder cancer (BIAS project): longitudinal cohort study

47. Single institution prospective validation and comparison of the the simplified PADUA REnal (SPARE) nephrometry system for the prediction MIC achievement in robotic partial nephrectomy

48. Xpert bladder monitor: Longitudinal clinical performance for avoiding un-necessary cystoscopies in patients under active surveillance for recurrent bladder cancer (BIAS project)

49. Potential role of micro-ultrasound in the differentiation between muscle-invasive and non-muscle invasive bladder cancer: A prospective analysis

50. Head-to-head comparison between high-resolution microultrasound imaging and multiparametric MRI in detecting and local staging of bladder cancer: The bus-miss protocol

Catalog

Books, media, physical & digital resources